Stefano Di Cecca

GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma

Francesca Del Bufalo, Biagio De Angelis, Ignazio Caruana et al. · New England Journal of Medicine · 2023 · 482 citations

Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia

Simona Caruso, Biagio De Angelis, Francesca Del Bufalo et al. · Journal of Hematology & Oncology · 2022 · 110 citations · Full text

Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia

Concetta Quintarelli, Simona Sivori, Simona Caruso et al. · Leukemia · 2019 · 92 citations · Full text

Hematological Malignancy, Cell Therapy, Malignant Blood Disorder +10

SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best

Ane Fernandez Salinas, Eva Piano Mortari, Sara Terreri et al. · Journal of Clinical Immunology · 2021 · 85 citations · Full text

CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T-cells

Marika Guercio, Domenico Orlando, Stefano Di Cecca et al. · Haematologica · 2020 · 69 citations · Full text

Adaptive Immune System, T-regulatory Cell, Immunology +21